Viral target and metabolism‐based rationale for combined use of recently authorized small molecule COVID‐19 medicines: Molnupiravir, nirmatrelvir, and remdesivir is a research paper published in Fundamental and Clinical Pharmacology (2023). On theSindex it has a DataRank of 0. It has been cited 18 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01AA030486
National Institutes of Health
Grant: R01AI172959
National Institutes of Health
Grant: R21HD109411
National Institutes of Health
Grant: R21AI153031
FWCI
3.06
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals